What’s coming for health science and policy in 2018? Global experts look ahead in their field
In PLOS Medicine’s first editorial of 2018, editorial board members and other leading researchers share their hopes, pleas, concerns, and expectations for this year in health research and policy.
Vyšlo v časopise:
What’s coming for health science and policy in 2018? Global experts look ahead in their field. PLoS Med 15(1): e32767. doi:10.1371/journal.pmed.1002498
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002498
Souhrn
In PLOS Medicine’s first editorial of 2018, editorial board members and other leading researchers share their hopes, pleas, concerns, and expectations for this year in health research and policy.
Zdroje
1. Feldman JM, Gruskin S, Coull BA, Krieger N. Quantifying underreporting of law-enforcement-related deaths in United States vital statistics and news-media-based data sources: A capture–recapture analysis. PLoS Med 2017. 14(10): e1002399. doi: 10.1371/journal.pmed.1002399 29016598
2. Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al. Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors. PLoS Med 2017. 14(6): e1002315. doi: 10.1371/journal.pmed.1002315 28582414
3. WHO Fact Sheet updated October 2017. Available from: http://www.who.int/mediacentre/factsheets/fs104/en
4. Abel L, Fellay J, Haas DW, Schurr E, Srikrishna G, Urbanowski M, et al. Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives. Lancet Infect Dis. 2017 Oct 27. pii: S1473-3099(17)30623-0. doi: 10.1016/S1473-3099(17)30623-0
5. Geadas C, Stoszek SK, Sherman D, Andrade BB, Srinivasan S, Hamilton CD, et al. Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international. Tuberculosis (Edinb). 2017 Jan;102:55–67. doi: 10.1016/j.tube.2016.11.006 28061953
6. Mahon RN, Hafner R. Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious Diseases. Front Immunol. 2017; 8: 688. doi: 10.3389/fimmu.2017.00688 28706516
7. Carrell S. Scotland’s minimum pricing for alcohol to take effect in May 2018. The Guardian 2017, 22 November. Available from: https://www.theguardian.com/society/2017/nov/21/scotlands-minimum-pricing-for-alcohol-to-take-effect-in-may-2018
8. Angus C, Holmes J, Pryce R, Meier P, Brennan A. Model-based appraisal of the comparative impact of Minimum Unit Pricing and taxation policies in Scotland. 2016 Sheffield: ScHARR, University of Sheffield. Available from: https://www.sheffield.ac.uk/polopoly_fs/1.565373!/file/Scotland_report_2016.pdf
9. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, et al. Alcohol: No Ordinary Commodity—Research and Public Policy. 2nd ed. 2010. Oxford, etc.: Oxford UP.
10. Burke L, AAP. Draft strategy proposes radical plan to boost booze prices. News.com.au website 2017, 20 December. Available from: http://www.news.com.au/lifestyle/food/drink/draft-strategy-proposes-radical-plan-to-boost-booze-prices/news-story/b3ec7d4d2678f518499bc27d0ad7e223
11. Minear T, Cambell J. Aussie drinkers face paying more for booze under radical health plan, Herald Sun 2017, Melbourne, December 19. Available from: http://www.heraldsun.com.au/news/aussie-drinkers-face-paying-more-for-booze-under-radical-health-plan/news-story/17f0dc185e450802a161fcf152fccd2b
12. Office for the Coordination of Humanitarian Affairs. 2018 Humanitarian needs overview—Yemen. Available from: https://www.unocha.org/yemen Cited12 December 2017
13. Hubbard B, Cumming-Bruce N. Rebels in Yemen Fire Second Ballistic Missile at Saudi Capital. The New York Times. Available from: https://www.nytimes.com/2017/12/19/world/middleeast/yemen-rebels-missile-riyadh.html Cited 21 December 2017
14. United Nations leaders call on the Saudi-led coalition to fully lift blockade of Yemeni Red Sea ports. UNICEF. 2 December 2017. Available from: https://www.unicef.org/infobycountry/media_101758.html
15. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–1722. doi: 10.1056/NEJMoa1615664 28304224
16. Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, et al. Cardiovascular efficacy and safety of bococizumab in high-risk patients. N Engl J Med. 2017;376:1527–1539. doi: 10.1056/NEJMoa1701488 28304242
17. Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372:1489–1499. doi: 10.1056/NEJMoa1501031 25773378
18. Hadjiphilippou S, Ray KK. Pcsk9 inhibition and atherosclerotic cardiovascular disease prevention: Does reality match the hype? Heart. 2017;103:1670–1679. doi: 10.1136/heartjnl-2016-310844 28596304
19. Ference BA, Cannon CP, Landmesser U, Luscher TF, Catapano AL, Ray KK. Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (pcsk9) inhibitors and statins: An analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J. 2017. doi: 10.1093/eurheartj/ehx450 29020411
20. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Kasteleinlammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131. doi: 10.1056/NEJMoa1707914 28845751
21. CDC gets list of forbidden words: Fetus, transgender, diversity. Washington Post. 15 December 2017. Available from: https://www.washingtonpost.com/national/health-science/cdc-gets-list-of-forbidden-words-fetus-transgender-diversity/2017/12/15/f503837a-e1cf-11e7-89e8-edec16379010_story.html
22. Uproar Over Purported Ban at C.D.C. of Words Like ‘Fetus’. New York Times, 16 December 2017. Available from: https://www.nytimes.com/2017/12/16/health/cdc-trump-banned-words.html
23. No, HHS did not “ban words”. The National Review. 18 December 2017. Available from: http://www.nationalreview.com/corner/454752/cdc-did-not-ban-words-yuval-levin
24. Secretary’s Minority AIDS Initiative Fund. Available from: https://www.hiv.gov/federal-response/smaif/overview
25. Byass P. Dr Tedros Adhanom Ghebreyesus is the best candidate for WHO DG. Lancet, 2017; 389 (10084):e6–e7. doi: 10.1016/S0140-6736(17)31354-5 28527706
26. Ghebreyesus TA. All roads lead to universal health coverage. Lancet Global Health, 2017; 5(9):e389–e840.
27. Vázquez TR, Ghebreyesus TA. Beating NCDs can help deliver universal health coverage. Lancet, 2017; 390 (10101):1473–1474. doi: 10.1016/S0140-6736(17)32470-4 28952441
28. World Health Organization. WHO Headquarters Leadership Team. Available from: http://www.who.int/dg/leadership-team/en/. Cited 15 December 2017
29. World Health Organization. WHO Priorities. Available from: http://www.who.int/dg/priorities/en/. Cited 15 December 2017
30. GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet. 2017;390:1423–1459. doi: 10.1016/S0140-6736(17)32336-X 28916366
31. Li Z, Li M, Subramanian SV, Lu C. Assessing levels and trends of child health inequality in 88 developing countries: from 2000 to 2014. Glob Health Action.2017;10(1):1408385. doi: 10.1080/16549716.2017.1408385 29228888
32. Vaivada T, Gaffey MF, Bhutta ZA. Promoting Early Child Development With Interventions in Health and Nutrition: A Systematic Review. Pediatrics. 2017;140(2). pii: e20164308. doi: 10.1542/peds.2016-4308 28771408
33. Watts N, Adger WN, Ayeb-Karlsson S, Bai Y, Byass P, Campbell-Lendrum D, et al. The Lancet Countdown: tracking progress on health and climate change. Lancet. 2017 Mar 18;389:1151–1164. doi: 10.1016/S0140-6736(16)32124-9 27856085
34. Sharma J, Osrin D, Patil B, Neogi SB, Chauhan M, Khanna R, et al. Newborn healthcare in urban India. J Perinatol. 2016;36(s3):S24–S31. doi: 10.1038/jp.2016.187 27924107
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 1
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Traumatic brain injury and the risk of dementia diagnosis: A nationwide cohort study
- Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort
- PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults